Clinical trialNCT04683653RecruitingPhase 1/PHASE2Interventional

Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer

SponsorUniversity of ChicagoEnrollment100Endometrial Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will investigate if a shorter treatment course (known as "hypofractionation") for pelvic radiation is safe for women with endometrial cancer. Doctors leading the study will also determine the safest and most tolerable dose of shortened radiation (hypofractionation) used to treat women in this study. Because this study will shorten the radiation course typically used to treat endometrial cancer, each daily treatment given to women in this study will be slightly higher than normal to ensure that the total radiation dose they receive is still effective and similar to the radiation dose they would receive if they were not participating in this study (standard treatment).

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Christina Son, MD
University of Chicago
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Winship Cancer Institute, Emory University
Atlanta, Georgia, United States
Active, not recruiting
University of Chicago
Chicago, Illinois, United States
Recruiting
University of Illinois at Chicago (uic)
Chicago, Illinois, United States
Christina Son
Recruiting
Md Anderson Cancer Center
Houston, Texas, United States
Anuja Jhingran,, MD
Recruiting
Huntsman Cancer Institute
Salt Lake City, Utah, United States
Gita Suneja, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 15 Jan 2021
Primary completion: 22 May 2027
Completion: 22 May 2027
Last update posted: 29 Dec 2025
Registered enrollment: 100
Registry id: NCT04683653

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.